This research develops rapid, low-cost diagnostics for Mycoplasma genitalium, a difficult-to-detect, drug-resistant STI. By replacing PCR with LAMP-based methods, it enables faster, accessible testing using minimal equipment and visual readouts. The approach aims to improve early detection, treatment, and health equity, particularly in low-resource settings facing rising infection rates.

This research improves water and clinical diagnostics by replacing slow culture-based methods with rapid DNA-based detection. It enables faster, more accurate identification of pathogens, comprehensive microbial profiling, and tracing of contamination sources. By leveraging DNA amplification and sequencing, the work aims to deliver quicker, more reliable, and preventative public health solutions.